Renal Mixed Epithelial Cells, Primary, 500,000 cells per vial

Cat.No.: CSC-C4068X

Species: Human

Source: Kidney

Cell Type: Epithelial Cell

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C4068X
Description
Creative Bioarray's normal Human Renal Epithelial Cells, when grown in Creative Bioarray's LIRen Medium, provide an ideal low-serum culture model for the study of renal function, metabolism, nephrotoxicity or cancer research. Creative Bioarray's Renal Mixed Epithelial Cells are cryopreserved as primary cells to ensure the highest viability and plating efficiency. Our Renal Epithelial Cells are quality tested in LIRen Medium to ensure optimal reduced-serum growth over a period of at least 15 population doublings at rates equal to or greater than serum-supplemented medium.

Cell Features:
Mixed Renal Epithelial, Renal Cortical Epithelial, and Renal Medullary Epithelial are cryopreserved as primary cells isolated from human kidney tissue and expanded in culture vessels once before cryopreservation.
Renal Proximal Tubule Epithelial are cryopreserved as secondary cells isolated from human kidney tissue and expanded in culture vessels twice before cryopreservation.
All Renal Epithelial Cell types can be grown in a 0.5% serum medium without phenol red or antimicrobials when cultured in LIRen Medium.
All Renal Epithelial Cell types are extensively tested for quality and optimal performance.
Creative Bioarray guarantees performance and quality.
Species
Human
Source
Kidney
Cell Type
Epithelial Cell
Disease
Normal
Storage and Shipping
Store in liquid nitrogen and ship in dry ice.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Primary Human Renal Mixed Epithelial Cells, as their name suggests, are an epithelial cell population derived directly from normal kidney tissue. These cells are "primary" because they are not immortalized cell lines. As a result, they maintain the phenotype of the tissue from which they are derived and tend to demonstrate morphology and functionality more relevant to the in vivo state.

Mixed epithelial cells obtained from the kidney are cobblestone in appearance and express epithelial cell markers such as Cytokeratin and E-cadherin. Since they are comprised of many different cell types originating from the nephron (proximal tubules, distal tubules, collecting ducts, etc.), they can be used to study cellular interactions between multiple cell types. Typical applications of these cells include:

  • Detection of Nephrotoxicity: Determine how cells respond to potential pharmaceutical drugs and environmental chemicals.
  • Renal Transport/Metabolism: Examination of transporters, electrolyte homeostasis, and metabolism.
  • Disease Modeling: Mechanisms of acute kidney injury (AKI), chronic kidney disease (CKD), fibrosis, etc.
  • Tissue Engineering: Cell therapy and tissue engineering studies.

These cells have limited lifespans due to their primary nature and require rich growth media containing hormones and growth factors to sustain their differentiated phenotype in culture. They act as an intermediary between standard cell culture and animal models.

Combination Treatment with PAC and ATRA Synergistically Inhibits the Proliferation of ADPKD Cells but Not HRECs

Autosomal dominant polycystic kidney disease (ADPKD) is characterized by uncontrolled epithelial cell growth, cyst formation, and kidney malfunction. Nguyen et al. investigated the antiproliferative effects of combining paclitaxel (PAC) and all-trans retinoic acid (ATRA) on ADPKD epithelial cells.

To find the optimal concentrations for combination treatment, cells were treated with various concentrations of PAC and ATRA. Treatment with 10 nM PAC alone reduced cell viability by 40% (Fig. 1a), while ATRA alone (10-1000 nM) had no significant effect (Fig. 1b). Fixing ATRA at 10 nM, they tested different PAC concentrations and found that 1 nM PAC combined with ATRA showed the most potent inhibitory effect (20% reduction in cell viability) compared to PAC alone. Other PAC concentrations were less effective (Fig. 1a). Fixing PAC at 1 nM, we confirmed the maximum inhibitory effect with at least 10 nM ATRA (Fig, 1b). These optimal concentrations (1 nM PAC and 10 nM ATRA) were verified with different incubation periods (Fig. 1c). Subsequent experiments used this combination (PAC+ATRA). PAC+ATRA did not affect primary normal human renal mixed epithelial cells (HRECs) viability (Fig. 1d), ensuring selective action on ADPKD cells. A wound healing assay showed that PAC+ATRA significantly slowed wound gap closure compared to DMSO controls (Fig. 1e and 1f), indicating suppression of ADPKD cell proliferation and migration.

Combination treatment with PAC and ATRA synergistically inhibits ADPKD cell proliferation. WT 9-7 cells were treated with PAC and ATRA.

Fig. 1. Combination treatment with PAC and ATRA synergistically inhibits ADPKD cell proliferation. WT 9-7 cells were treated with PAC and ATRA (Nguyen QTT, Hoang TX, et al., 2021).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products